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INTRODUCTION 
 Hydrocephalus is an accumulation of excess CSF in the ventricular 
system of brain due to an increased secretion, defective absorption or 
disturbances in CSF circulation. The most significant contribution to the 
treatment of hydrocephalus was made by Nulsen and Spitz1, who in 1952, 
first performed the valve- regulated shunt system to prevent the reflux of 
venous blood.  In 1908, Cushing3 first performed the Ventriculo-
peritoneal(VP) shunt, but that did not gained popularity until after the 
publications of Scarff’s2 work in 1963. Ventriculo – peritoneal shunt 
placement is a relatively common neurosurgical procedure performed for 
the treatment of hydrocephalus. One of the principal complications 
associated with the use of these devices is infection, with infection rates 
ranging from 1.5 to 38%. Age seems to be an important risk factor, with 
neonates and young children frequently affected.  Shunt infection leads to 
severe morbidity for the patient. Of even greater concern is the infection 
related mortality, with rates up to 20% reported in the literature. 
 Though several authors have adopted several protocol and reduced 
the incidence of shunt infection. Considering the morbidity, mortality and 
the financial burden in treating shunt infections there is a need to evolve a 
strategy to prevent shunt infection completely and to bring the incidence 
to 0% .  
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AIM OF STUDY 
 To formulate a strategy for prevention of Ventriculo-peritoneal 
shunt infections. 
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REVIEW OF LITERTURE 
 The literature is reviewed under the following headings: 
1. Pathophysiology of Hydrocephalus. 
2. Treatment of Hydrocephalus. 
3. Shunt infection. 
4. Various studies on prevention of shunt infection. 
1. PATHOPHYSIOLOGY OF HYDROCEPHALUS: 
 The Cerebrospinal fluid(CSF) is produced at the rate of 0.33ml/ mt 
by two distinct processes. First, by an energy- requiring process 
performed by the choroid plexuses in the lateral, third and fourth 
ventricles. This process depends on the enzyme Carbonic anhydrase  and 
can be blocked by Acetazolamide. The remainder of the CSF is produced 
as a by- product of cerebral and white matter metabolism. After its 
production CSF flows from lateral ventricle to third ventricle via foramen 
of monro, from there it reaches the fourth ventricle through the aqueduct 
of sylvius. From the fourth ventricle the CSF exits through the foramen of  
Lushka and Megendie to reach the cistern magna to get mixed with the 
CSF from spinal subarachnoid space. Finally the CSF flows through the 
cortical subarachnoid space to be absorbed through the arachnoid villi in 
to the sagittal sinus. The energy for circulation of CSF is generated by the 
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pumping of arterial blood in to the choroid plexus. A pressure differential 
can be measured between the cranial subarachnoid space and the sagittal 
sinus4-5, which ranges from 5 and 7mmHg. This is defined as the opening 
pressure below which no absorption occurs. 
Engelhard et al postulated three forms of hydrocephalus14: 
1. Disorders of CSF production: This is the rarest form of 
hydrocephalus. Choroid plexus papillomas and choroid plexus 
carcinomas can secrete CSF in excess of its absorption. 
2. Disorders of CSF circulation: This form of hydrocephalus results 
from obstruction of the pathways of CSF circulation. This can 
occur at the ventricles due to CSF flow obstruction by tumors, 
hemorrhages and congenital malformations (such as aqueductal 
stenosis). 
3. Disorders of CSF absorption: Conditions, such as the superior vena 
cava syndrome and sinus thrombosis, can interfere with CSF 
absorption. Some forms of hydrocephalus cannot be classified 
clearly. This group includes normal pressure hydrocephalus and 
pseudotumor cerebri. 
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Clinical Features: 
 The various types of hydrocephalus can present differently in 
different age groups15. Acute hydrocephalus typically presents with 
headache, gait disturbance, vomiting, and visual changes. In infants, 
irritability or poor head control can be early signs of hydrocephalus. 
When the third ventricle dilates, the patient can present with Parinaud 
syndrome (upgaze palsy with a normal vertical Doll’s eye response) or 
the setting sun sign (Parinaud syndrome with lid retraction and increased 
tonic downgaze). Occasionally, a focal deficit, such as sixth nerve palsy, 
can be the presenting sign. Papilledema is often present, although it may 
lag behind symptomatology. Infants present with bulging fontanelles, 
dilated scalp veins, and an increasing head circumference. When 
advanced, hydrocephalus presents with brainstem signs, coma, and 
hemodynamic instability. Normal pressure hydrocephalus has a very 
distinct symptomatology. The patient is older and presents with 
progressive gait apraxia, incontinence, and dementia. This triad of 
symptoms defines normal pressure hydrocephalus. 
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TREATMENT OF HYDROCEPHALUS: 
 Cerebrospinal fluid shunting is the well-accepted standard 
treatment for childhood hydrocephalus. There is a vast array of shunting 
devices with different components, all having similar features. The 
currently used shunt systems have valve systems incorporated in the 
shunt with an opening and closing pressure so that currently used shunts 
are, for the most part, pressure regulated. Given the fact that shunt 
systems all drain CSF relatively quickly once the child assumes an 
upright posture due to the effect of siphoning, most flow characteristics in 
currently used shunts are relatively unimportant. There are other technical 
aspects of shunt insertion which are far more important to maintain 
adequate shunt function then the specific details of the shunt valve 
characteristics. An ideal shunt still needs to be the goal in the future of 
treating hydrocephalus. The ideal shunt would allow for a flow regulated 
control to drain a specific amount of fluid, which could be tailored to an 
individual child's needs. In addition, there would be the ability to monitor 
externally shunt function and potential shunt malfunction. This ideal 
valve would allow the drainage of only the amount of fluid that is really 
excess for a given child, and may avoid the problems of shunt 
dependency. The currently used valves, however, as mentioned above, 
are still pressure regulated. Shunt valve systems can be located proximal, 
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as well as distal. Distal slit valves are now to be avoided because of the 
high frequency of distal shunt malfunction, as well as unpredictable flow 
characteristics. Valve mechanisms include slit valves, spring-ball valves 
or diaphragm valves16. The slit valve is somewhat unpredictable, and 
flow can vary markedly given the amount of previous irrigation or the 
stickiness of the valve. Spring-ball and diaphragm valves maintain a more 
constant flow rate. Siphoning is a factor which comes into play when a 
child assumes an upright position and a negative pressure is exerted, 
which is related to the vertical distance between the inlet and the outlet of 
the shunt. In rare cases in which siphoning appears to be detrimental to a 
child, an antisiphon device17 can be inserted to negate this negative effect 
only in the vertical position. The characteristics to be aware of is that 
shunt valves are described by the pressure above which CSF will flow, as 
well as resistance to flow. A valve can be low pressure but have a high 
resistance so that the rate at which fluid flows down to the closing 
pressure of the shunt will be a gradual drop off . A low resistance valve 
will drop quickly and then stop abruptly when the fluid pressure reaches 
the closing pressure of the valve. These are rarely  used in the placement 
of childhood shunts. Occasionally, however, there is a situation where a 
child is having low pressure symptoms or recurring proximal shunt 
occlusions due to collapse of the ventricles around the ventricular 
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catheter, and an antisiphon device may be useful to help control this form 
of slit ventricle syndrome. One needs to be careful about the use of 
antisiphon devices, since it may slow down the function of the shunt too 
much and cause symptoms that are due to inadequate shunt function18. 
This is particularly important in infants, if the antisiphon device is used 
with a medium pressure shunt. An antisiphon device works only when 
there is a negative pressure exerted due to the vertical position of a child, 
and the resultant siphoning. It consists of a diaphragm that covers the 
inlet to the device, and when there is a negative pressure exerted from 
below the diaphragm moves downward occluding the inlet so that the 
shunt is essentially closed. In this way, this closes the shunt only when 
there is negative pressure present in the distal part of the system. 
Hydrocephalus must be treated to prevent brain mass damage by 
ventriculomegaly. Therefore the goal of treating ventriculomegaly is to 
prevent the microscopic damage that results if left untreated. This is 
achieved by CSF diversion. The various CSF diversion procedures are  
1. Ventriculo-peritoneal shunt 
2. Ventriculo-atrial shunt 
3. Ventriculo-pleural shunt 
4. Ventriculo-subgaleal shunt. 
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 Other distal sites occasionally used are gall bladder, ureter, bladder, 
sagittal sinus. As the Ventriculo-peritoneal shunt is the most common 
CSF diversion procedure done, it is described below. 
Ventriculo-peritoneal shunt: 
 The patient is positioned supine with head turned towards opposite 
shoulder and the neck is hyperextended.  Ratios of head circumference 
and catheter length are 5:1 for patients younger than 1month, 4.5:1 for 
patients between 1month to 5years and 4:1 for patients older than 5years6.  
Ventricular catheter can be placed through any of these commonly used 
burrholes. 
1. Kocher’s point: 11cm from nasion, 2.5cm from midline and 
1cm anterior to coronal suture. 
2. Keen’s point: 2.5cm posterior and superior to highest point 
of helix. 
3. Dandy’s point: 4cm superior to inion and 3.5cm lateral to 
midline. 
 Ideally the ventricular catheter tip should lie 1cm anterior to the 
foramen of Monro in the frontal horn of lateral ventricle7. The abdominal 
incision can be in the mid or upper abdomen on the side of ventricular 
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catheter. Anterior rectus sheath is opened parallel to the fibres. The rectus 
abdominis muscle is divided bluntly in vertical orientation. Posterior 
rectus sheath is next incised followed by the peritoneum. The shunt 
passer should be passed from the retro-auricular region to the abdominal 
incision. Once the shunt passer is passed in, the trocar is removed and the 
peritoneal catheter is fed in. The proximal system is then connected and 
the valve should be purged to ascertain good distal flow. Both the wounds 
are then closed in layers. 
Ventriculoatrial shunting:  
 This procedure is usually the first choice for patients who are 
unable to have distal abdominal catheters (eg, multiple operations, recent 
abdominal sepsis, known malabsorptive peritoneal cavity, abdominal 
pseudocyst).  The insertion of the distal catheter in to the cardiac atrium is 
performed by a skin incision made 3cm below the mandibular angle. The 
platysma is divided and the deep cervical fascia opened and the common 
facial identified and dissected for atleast 1cm from its entry in to the 
internal jugular vein. The cranial part is ligated and a suture is placed 
around the cardiac part of facial vein. The wall of the vein is incised and 
the catheter inserted inside it in the direction of the jugular. The tip is 
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placed in the right cardiac atrium at the level of the 8th rib confirmed by 
either X-ray or fluoroscopy. 
 The procedure carries more risk8. Long-term complications are 
more serious (eg, renal failure, great vein thrombosis). Fluoroscopic 
guidance is necessary to prevent catheter thrombosis (short distal 
catheter) or cardiac arrhythmias (long distal catheter). 
Ventriculopleural shunting:  
 This procedure is usually performed for patients with failed 
peritoneal and atrial shunts.  The distal catheter is placed using a skin 
incision placed just below the breast in the midclavicular line. The 
incision is deepened and the rib muscles are divided at the superior aspect 
of the lowest of the two selected ribs and a self-retaining retractor is 
placed between them. A small hole is placed in the pleura and the distal 
catheter is inserted in to it. The pleura is closed with a purse string suture 
around the tubing. A control chest X-ray is usually taken post-
operatively. 
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Shunt system valves: 
1. Differential pressure valves: 
                ÆSlit valves 
                                Æ Mitter valves 
            ÆDiaphragm valves 
                               ÆBall in cone valves. 
2. Programmable valves: 
              Externally adjustable differential pressure valves. 
3. Flow- regulated valves. 
4. Anti-siphon devices. 
5. Gravity actuated valves. 
Torkildsen shunts or internal shunts: 
 These are straight tubes that communicate to cerebrospinal fluid 
spaces without a valve. Their effectiveness and long-term efficacy are not 
proven. 
Endoscopic third Ventriculostomy:  
 The first open third ventriculostomy was performed by Walter 
Dandy in the 1910s with moderate success and has recently experienced 
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resurgence with the introduction of operating endoscopes. The 
endoscopic equipment has improved, which has resulted in increased use 
of the procedure. ETV has a success rate of 70% when used in patients 
with aqueductal stenosis and is regarded by many as the procedure of 
choice in these patients. Endoscopic cyst fenestration can be used in the 
presence of arachnoid cysts in various locations (ie, suprasellar, 
interhemispheric, posterior fossa) with variable success. Third 
ventriculostomy has been recently performed to treat hydrocephalus in 
children with myelomeningocele. However, the reported success rates are 
only approximately 30-40%. One possible explanation for the low 
success rate of third ventriculostomy is that most patients are infants or 
neonates when they receive initial treatment and do not have fully 
developed subarachnoid spaces. A frontal ventricular catheter attached to 
a blind reservoir or an Ommaya reservoir can be left in place and can be 
converted to a ventriculoperitoneal shunt if the third ventriculostomy 
fails. ETV can be used in children who have already received shunting 
and who present with shunt malfunction at an older age. 
 The reported success rate is approximately 50%. In such patients, an 
external ventricular drain should be used for the first few days following 
third ventriculostomy (especially if the shunt has been removed) to allow 
emergency decompression if the third ventriculostomy does not function 
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adequately and the patient’s condition rapidly deteriorates. ETV may be 
more effective if it is combined with choroid plexus cauterization. 
Improved outcomes were reported in a recent study of select patients 
younger than one year. However, cauterization is not routinely performed 
and remains a controversial option; further study is needed. ETV is 
traditionally performed through a frontal burr hole situated just anteriorly 
to the coronal suture. A rigid or flexible endoscope is preferred. The third 
ventricle floor is perforated using a purpose-designed monopolar 
diathermy with retractable tip or another similar purpose-designed 
dissector. After formation, the stoma is commonly dilated using some 
kind of purpose-designed balloon dilator. Perforation of the third 
ventricle floor is the most delicate and important phase because 
perforation of the adjacent basilar artery is a risk. ETV can be particularly 
difficult in children with myelomeningocele because the ventricular 
anatomy is often abnormal, the third ventricle floor is thicker and more 
difficult to penetrate, the size of the third ventricle is smaller in these 
children than in those with aqueductal stenosis, or the septum pellucidum 
is absent, which can lead to disorientation in the inexperienced operator. 
In general, inexperienced operators should avoid ETV in children with 
hydrocephalus caused by myelomeningocele. Apart from damage to the 
basilar artery, another potential source of intraoperative difficulty is 
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damage to the choroid plexus, which can lead to hemorrhage that clouds 
the operative field. Most nonarterial bleeding stops with gentle warm 
irrigation. Failure to perforate the Liliequist membrane may also result in 
ETV failure. Preoperative MRI is very important because it reveals the 
bowing of the third ventricle floor and its relationship to the basilar 
artery. Bowing of the third ventricle floor correlates with a pressure 
gradient between the ventricular system and the extraventricular CSF 
spaces. If the third ventricle floor is not bowed, the success rate of ETV is 
significantly decreased. In cases of shunt revision or shunt removal after 
successful ventriculostomy, rupture of the choroid plexus during retrieval 
of the ventricular catheter is common and can lead to life-threatening 
hemorrhage. Different techniques can be used to avoid this complication; 
the most common of these techniques involves insertion of a stylet into 
the catheter lumen, allowing for coagulation with the diathermy before 
the catheter is retrieved. However, if the ventricular catheter is not easily 
removed, it should be left in place and an additional catheter should be 
placed. Image guidance can also be very helpful in ventricular catheter 
placement, especially in patients with loculated hydrocephalus and 
cannulating complex cysts.  
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Contraindication for treatment of hydrocephalus: 
 Few cases of hydrocephalus should not be treated. Cases in which 
treatment should not be implemented include the following: 
• In ventriculomegaly of senescence, the patient who does not have 
the symptom triad. 
• Ex vacuo hydrocephalus is merely the replacement of lost cerebral 
tissue with cerebrospinal fluid. Because no imbalance in fluid 
production and absorption exists, this technically is not 
hydrocephalus. 
• Arrested hydrocephalus is defined as a rare condition in which the 
neurologic status of the patient is stable in the presence of stable 
ventriculomegaly. The diagnosis must be made extremely carefully 
because children can present with very subtle neurological 
deterioration (eg, slipping school performance) that is difficult to 
document. 
• Benign hydrocephalus of infancy is found in neonates and young 
infants. The children are asymptomatic, and head growth is normal. 
CT scan shows mildly enlarged ventricles and subarachnoid 
spaces. 
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Complications 
 The most common complications differ depending on the type of 
shunt and the underlying pathophysiology.   
1. Infection9 is the most feared complication in the young age 
group. The overwhelming majority of infections occur within 6 
months of the original procedure. Common infections are 
staphylococcal10, 11, 12  and propionibacterial. Early infections 
occur more frequently in neonates and are associated with 
more virulent bacteria such as Escherichia coli. Infected shunts 
need to be removed, the cerebrospinal fluid (CSF) needs to be 
sterilized, and a new shunt needs to be placed. Treatment of 
infected shunts with antibiotics alone13 is not recommended 
because bacteria can be suppressed for extended periods and 
resurface when antibiotics are stopped.  
2. Subdural hematomas occur almost exclusively in adults and 
children with completed head growth. Incidence of subdural 
hematomas can be reduced by slow postoperative mobilization 
and perhaps by avoiding rapid intraoperative ventricular 
decompression. This allows for brain compliance reduction. 
The treatment is drainage and may require temporary occlusion 
of the shunt.  
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3. Shunt failure is mostly due to suboptimal proximal catheter 
placement. Occasionally, distal catheters fail. Suspect infection 
if the distal catheter is obstructed with debris. 
4.  Abdominal pseudocysts are synonymous with low-grade shunt 
infection.  
5. Overdrainage is more common in lumboperitoneal shunts and 
manifests with headaches in the upright position. In most cases, 
overdrainage is a self-limiting process. However, revision to a 
higher-pressure valve or a different shunt system occasionally 
may be necessary. A positional valve that closes when the 
patient is upright is also available.  
6. Slit ventricle syndrome is an extremely rare condition in which 
brain compliance is unusually low. It mostly occurs in the 
setting of prior ventriculitis or shunt infection. The patient may 
develop high pressures without ventricular dilatation. The slit 
ventricle syndrome does not imply overdrainage, and the 
symptoms usually are those of high pressure rather than low 
pressure. Most experts also agree that slit ventricles predispose 
the patient to a higher incidence of ventricular catheter failure. 
Repeated ventricular blockage by the coapted ventricular wall 
may be helped by performing a subtemporal decompression 
that creates an artificial pressure reservoir and induces slight 
reenlargement of the slit ventricle. 
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Medical Therapy: 
 Medical therapy is usually a temporizing measure. In transient 
conditions, such as sinus occlusion, meningitis, or neonatal 
intraventricular hemorrhage, medical therapy can be effective. 
• Acetazolamide (25 mg/kg/d in 3 doses): Careful monitoring of 
respiratory status and electrolytes is crucial. Treatment beyond 6 
months is not recommended. 
• Furosemide (1 mg/kg/d in 3 doses): Again, electrolyte balance and 
fluid balance need to be monitored carefully. 
• Theobromine sodiosalicylate appears to have a very definite effect 
in increasing surface tension and checking oedema of the tissues 
and the idea suggested itself to Marriott et al that in the 
communicating type hydrocephalus, absorption of the spinal fluid 
by the subarachnoid might be favoured by raising the surface 
tension within the blood vessels by the administration of this 
theobromine sodiosalicylate. Acting on this hypothesis 
theobromine sodiosalicylate was administered to infants in whom 
previously there had been a marked and persistent increase in the 
circumference of the head notwithstanding repeated rachicenteses. 
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The dosage given was 0.2gms three times a day continued over a 
considerable period of time.  Gerstenberger et al of Cleveland, and 
Blackfan et al of Boston, both corroborated these results. 
• Lumbar punctures: In neonates recovering from intraventricular 
hemorrhage, serial lumbar punctures can, in some cases, resolve 
hydrocephalus. If possible, this is the preferred method of 
treatment.  
• Removal of the underlying cause usually resolves hydrocephalus. 
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SHUNT INFECTION: 
 Shunt infection is the most dreaded complication of VP shunt with 
ranges from as low as 1.5% to 38%. Various researchers have analysed 
the incidence of shunt infection in various studies20,21 and are as follows : 
Author No. of patients Year of study Infection rate
Walters and colleagues 1500 1960-1979 18% 
Ammirati and Raimondi27 431 1973-1982 22% 
Borgbjerg9 and associates 884 1958-1989 6.2% 
Casey10 and colleagues 155  9-19% 
ISPN  1994 6.5% 
 
Mancao et al 268 1998 10.8% 
Lakshmi et al 226 2006 3.98% 
Thompson 108 2007 6.48% 
Inayatullah et al 151 2009 1.98% 
 
Time to infecton: 
 Majority of  the researchers found that most of the shunt infections 
occur in the first 3 months following shunt10-11. 
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Risk factor for infections: 
1. Extremes of age: 
 A variety of explanations exists for increased infection among very 
young children, including the presence of age- related changes in the 
density and identity of bacterial populations on the skin of neonates, as 
well as increased susceptibility to pathogens due to relative deficiency of  
the neonatal immune system. In particular children younger than 6 
months have immunoglobulin G levels that are approximately half that of 
the adults. Also there is evidence that highly adherent strains of 
Staphylococcus occur among children younger than 6 months than among 
older children. 
2.   Cause for hydrocephalus: 
 Post- Haemorrhagic hydrocephalus has higher incidence of 
infection. Dallacasa and associates reported that half the children in the 
post-haemorrhagic and post-infectious group had at least one infection by 
the end of 1year. 
3.     Type of shunt: 
 Two larger studies reported that Ventriculo-peritoneal shunts had 
the  highest rates of infection. 
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4.  Presence of spinal dysraphism: 
 Ammirati and colleagues demonstrated that children with 
myelomeningocoele who were shunted in the first week of life had a two 
fold increase in the incidence of infection relative to those shunted at 
2weeks or later. 
5.  Competence of the surgeon. 
6.  Time period of surgery. 
7.  Duration of surgery. 
8.  Use of antibiotics before and after surgery. 
Clinical presentation: 
 The presentation is variable and is age dependent but commonly 
includes headache, vomiting and lethargy. Infants may present with 
irritability and in severe cases with apnea and bradycardia. Additional 
complaints includes fever , gait disturbances, seizures, Visual 
disturbances, papilledema, abdominal pain, erythema or edema along 
shunt tube tract. The presentation also depends on the type of infecting 
organisms. E.coli infections may present acutely with septicemia and 
severe abdominal pain. Staph epidermidis infection will have an indolent 
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course and staph aureus infection will present with induration along shunt 
tube tract19. 
Organisms: 
 CSF shunt catheter infections occur via three routes: the blood 
stream, along shunt tube tract from abdominal route and contamination of 
the shunt material with skin organisms at the time of surgery. The most 
common organism is Staph epidermidis followed by Staph aureus. Staph 
epidermidis secretes a mucoid material that enhances its ability to adhere 
to foreign material. Shunt infections with gram negative organisms like 
E.coli, Klebsiella. Proteus are also common. Delayed infection with 
anaerobic organisms like Propianibacterium are difficult to access and 
treat. Fungal infections are also reported but are very rare. Infection can 
be defined as the presence of positive CSF culture or alternatively 
positive culture from shunt tube hardware. But in most instances, only the 
shunt hardware tests positive for bacterial or other growth and fluid itself 
remains negative. A hypothesis explains that bacteria and other 
microorganisms favor adhesion to foreign material than CSF. 
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Treatment: 
        Majority of the shunt infections are currently treated by surgical 
removal of the infected shunt22,23,24,25. A new device is then placed either 
at the time of removal of infected shunt or  at a later date. In many 
instances shunt replacement are delayed until the CSF cultures are 
negative. The recommended interval between shunt removal and 
reinsertion ranges fro 10 to 14 days. 
 An alternative to surgical replacement is the use of antibiotics 
alone. The method of administration of antibiotics is extremely important, 
with the addition of intrathecal antibiotics associated with increased rates 
of cure and survival. 
Outcomes: 
 In a series of 108 infants presenting with hydrocephalus at birth 
and operated from 1971-1981, Renier et al reported a 10-year survival 
rate of 71% in non-infected, versus 51% in infected children. Similarly 
Walter and colleagues reported mortality rate of 34% in infected, versus 
18% in non-infected patients. Mc Lone et al found that shunted children 
with infections had a significantly lower IQ(76+/-26) than did shunted 
children without infection(95+/-19). 
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SHORT REVIEW OF VARIOUS STUDIES ON PREVENTION OF 
SHUNT INFECTION: 
1.    Randolph31 et  al (1979), published a retrospective analysis of 840 
cerebrospinal fluid shunting procedures over a 25-year period to 
determine the relationships between infection rates and several 
possible influences on infection. Two-thirds of all shunt infections 
occurred within 1 month of surgery. The very young and very old 
had higher infection rates. Infections became less prevalent over 
the period of the study, and mortality from infection decreased 
from 35% to 6%. Successive shunts (revisions) were found to have 
progressively higher infection rates. Ventriculoatrial and 
ventriculoperitoneal silicone plastic shunts had similar infection 
rates (11.4% and 12.0%). The uncontrolled use of prophylactic 
antibiotics had no effect on shunt infections. Staphylococcus 
epidermidis became gradually more prevalent over the period of 
the study, and eventually caused one-half of all infections. Where 
infection occurred in the presence of prophylaxis, the infectious 
organism was usually sensitive to the antibiotic being used. The 
surgeon was found to be the largest single factor in the incidence of 
shunt infections. A 25-fold variance in infection rates among 
surgeons could be related to individual experience and technique. 
27 
 
2.     Kevin32  et al (1983) a review on the clinical manifestations and 
therapy of hydrocephalus shunt infections in 32 patients with a 
total of 35 shunt infections. These 35 infections accounted for 43 
hospital admissions. First infections usually developed within 2 
months following surgery. At the time of diagnosis, 89% of 
patients were febrile. Fever and cough as a symptom complex 
characterized the initial clinical presentation in six of 19 episodes 
of infection complicating ventriculoatrial (VA) shunts, as 
compared with none of 21 episodes in which infection complicated 
ventriculoperitoneal (VP) shunts. Seven of 21 infectious episodes 
occurring in patients with VP shunts in situ were associated with 
significant abdominal pain and tenderness. These patients usually 
had no other clinical features to suggest shunt infection. Both of 
these symptom complexes often led to delays in diagnosis and 
treatment. Causative organisms included Staphylococcus 
epidermidis in 21, Staphylococcus aureus in seven, Gram-negative 
aerobic bacilli in seven, diphtheroids in five, Streptococcus species 
in four, and anaerobes in three. Five infections were polymicrobial 
in nature. Positive blood cultures were seen in 13 of 17 infectious 
episodes complicating VA shunts, as compared with only three of 
13 other infections. When the shunt was completely removed, with 
28 
 
or without replacement, all 13 patients were cured. When 
intravenous antibiotics were administered in conjunction with 
incomplete shunt removal, only eight of 15 courses resulted in 
cure. Intraventricular antibiotics were administered in four patients 
and all were cured. Therapy of shunt infections with parenteral 
antibiotics and incomplete shunt removal is associated with an 
unacceptably high failure rate. 
3.        Choux26 et al (1992) published a series of 600 cases with 1197 VP 
shunts done following a protocol and reduced the infection rate to 
0.33%. The protocol he followed has many factors observed during 
pre-operative, per-operative and post-operative period. During the 
preoperative period, the patient was assessed for localized skin 
problem,  general medical condition,  no pre-op shaving of scalp 
and no pre-op antibiotic medications was used. All the shunts were 
posted early in the morning, before other operations and neonates 
& infants were operated before older children in the list. Not more 
than four shunt procedures were done per day. All shunts were 
done within 20 to 40 mts period. Only four people were allowed  in 
the operating room (surgeon, assistant, anesthesiologist, circulating 
nurse) no scrub nurse. All the shunts were done by an experienced 
neurosurgeon. The sterile shunt tube packaging was opened at the 
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last moment just before its insertion and no valve testing done. 
During surgery, meticulous hemostasis was achieved and great care 
taken for careful siting of valve/reservoir. Perfect skin closure was 
done for all cases. Prophylactic intravenous antibiotic was used 30 
mins before skin incision. In the postoperative period, head is 
positioned to avoid pressure on the valve. No antibiotic 
medications were  used. The approximate length of stay in hospital 
was 4 days for first time shunt  and 2 days for shunt revision 
patients. 
4.       Kulkarni28 et al(1999),  prospectively analyzed perioperative risk 
factors for CSF shunt infection in a cohort of children between 
1996 and 1999. 299 eligible patients underwent CSF shunt 
operations (insertions and revisions) that were observed by a 
research nurse at a tertiary care pediatric hospital. Several 
perioperative variables were recorded. All cases were followed 
postoperatively for 6 months to note any development of CSF 
shunt infection. Various perioperative variables were recorded in 
the study. The patient’s  age, sex , weight (kg), cause of 
hydrocephalus (intraventricular hemorrhage, myelomeningocele, 
tumor, aqueductal stenosis, meningitis, trauma, others, unknown), 
length of pre-op hospital stay,  presence of previous shunt system 
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and priority level of operation were recorded. Intraoperatively the 
timing of surgery, use of prophylactic antibiotic agents w/in 30 
mins of 1st incision, duration of operation from 1st incision until 
final wound closure, total number of persons present in operating 
room at any time during operation, presence of holes in surgical 
gloves,  number of times shunt system was inadvertently exposed 
to breached surgical gloves,  number of times shunt system was 
manipulated by a surgical instrument, lowest recorded 
intraoperative core body temperature (°C),  use of surgical 
ultrasound or endoscope during operation were recorded. Operating 
room score was calculated as sum of the following factors like 
number of holes present in sterile drapes, number of persons 
wearing stained operating scrub suits or stained shoes, number of 
persons wearing reused operating head covers, number of persons 
wearing operating mask with nose left uncovered, number of 
persons incorrectly gowned, number of persons with cuff of gown 
exposed over gloves, number of times sterile drapes were applied 
incorrectly or moved, number of times a person not appropriately 
scrubbed & gowned leaned over operative field or was within 1 ft 
of operative field, number of times light handles were 
contaminated.  Postoperatively, presence of CSF leak from 
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operative wound was recorded. At the end of the study, three risk 
factors for the development of CSF shunt infection have been 
identified, and changes in clinical practice should address them as 
follows.  
 1)  Great care should be taken intraoperatively to avoid a 
postoperative CSF leak.  
 2)  Alternatives to CSF shunt placement in premature infants 
should be studied and such patients should be considered 
high risk. 
 3)  Surgeons should minimize manual contact with the shunt 
system and consider the use of double gloves. These findings 
may have implications for other clean surgeries involving 
implantation of prosthetic devices and biomaterials. 
5. Scuibba35 et al (2005) published a study in which he retrospectively 
reviewed all pediatric patients who had undergone cerebrospinal 
fluid (CSF) shunt insertion at their institution over a 3-year period 
between April 2001 and March 2004. During the 18 months prior 
to October 2002, all CSF shunts included standard, 
nonimpregnated catheters. During the 18 months after October 
2002, all CSF shunts included antibiotic-impregnated catheters. All 
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patients were followed up for 6 months after shunt surgery, and all 
shunt-related complications, including shunt infection, were 
evaluated. The independent association of AIS34 catheter use with 
subsequent shunt infection was assessed via multivariate 
proportional hazards regression analysis. A total of 211 pediatric 
patients underwent 353 shunt placement procedures. In the 18 
months prior to October 2002, 208 (59%) shunts were placed with 
nonimpregnated catheters; 145 (41%) shunts were placed with AIS 
catheters in the 18 months after October 2002. Of patients with 
nonimpregnated catheters, 25 (12%) experienced shunt infection, 
whereas only two patients (1.4%) with antibiotic-impregnated 
catheters experienced shunt infection within the 6-month follow-up 
period (p < 0.01). Adjusting for intercohort differences via 
multivariate analysis, AIS catheters were independently associated 
with a 2.4-fold decreased likelihood of shunt infection. From which 
he concluded that the AIS catheter significantly reduced incidence 
of CSF shunt infection in children with hydrocephalus during the 
early postoperative period (< 6 months). The AIS system used is an 
effective instrument to prevent perioperative colonization of CSF 
shunt components.  
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6. Thompson8 et al conducted a prospective study of pediatric patients 
undergoing primary shunt insertion in 2007. He collected three 
swab samples from the surgical wounds during each procedure. 
These samples were incubated and subcultured, and the isolates 
were identified and stored. In patients who subsequently presented 
with clinical evidence of shunt infection, cerebrospinal fluid (CSF) 
was analyzed using microscopy, tissue cultures, and sensitivity 
testing. The organisms isolated at the time of shunt insertion and 
those responsible for subsequent shunt infection were then 
compared. The study population consisted of 107 pediatric 
patients. Because one patient underwent placement of an additional 
contralateral shunt system, there were 108 total shunt insertions 
yielding 325 swab samples. Organisms were identified in cultures 
of 50 swab samples (15%) obtained in 40 patients (37%). In seven 
of these 40 patients (17.5%) a CSF infection subsequently 
developed. In only one patient was the infectious organism the 
same as that isolated from the swab specimens. In an additional six 
patients (8.8%) a CSF infection occurred despite the lack of growth 
in the cultures from intraoperative swab samples. From the study 
he concluded that the organisms responsible for shunt infection 
were rarely detected in the operative wound at the time of shunt 
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insertion, leading the authors to conclude that the vulnerable period 
for bacterial colonization of shunts may not be restricted to the 
operative procedure as is commonly believed, but may extend 
throughout the postoperative period of wound healing. These 
findings have implications not only for a better understanding of 
the cause of shunt infections but also for the development of 
strategies to prevent them. 
7. Khan et al (2009), conducted a retrospective case study with 
nonrandomized convenience sampling. He studied 121 patients 
who underwent neurosurgical shunt operations during year 1994 to 
1999. These patients received pre, per and post operative 
antibiotics to combat shunt infection. Study design was 
retrospective case study with non randomized convenience 
sampling. He found that out of 121 patients, 65 patients were 
females and 56 males. The total number of shunts procedures 
performed in these patients was 151. Ninety-seven patients 
operated once for shunt procedure. Eightythree  patients underwent 
ventriculo-peritoneal shunt, 10 patients underwent lumboperitoneal 
shunt, 3 had ventriculo-pleural shunt and 1 had ventriculo-atrial 
shunting done. Three patients developed shunt infection, only one 
had true primary infection. All were 
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adults with male to female ratio of 2 to 1 and in all of them shunt was 
inserted first time. He concludd that strict aseptic technique and 
prophylactic use of antibiotics have critical role in the prevention of shunt 
infections. 
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MATERIALS AND METHODS 
 This study was done prospectively in 486 cases admitted in 
Institute of Neurology, Government General Hospital, Chennai during the 
period from 2006 – 2010. 
Inclusion criteria:  
 All patients with Congenital hydrocephalus, Tumour associated 
hydrocephalus,  Hydrocephalus associated with spinal dysraphism, 
Normal pressure hydrocephalus, Post-meningitic Hydrocephalus without 
active meningitis were included.  
Exclusion criteria: 
 Immunocompromised patients with Hydrocephalus, Hydrocephalus 
associated with active meningitis, Patients having skin diseases, Patients 
with focal sepsis.  
 The Patients were divided in to two groups, 
Group 1: Ventriculo-peritoneal shunt was done based on  protocol to 
reduce shunt infection 
Group 2 : No protocol was followed while doing the shunt. 
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Group 1  patient’s Ventriculo-peritoneal shunt was done based on the 
protocol. The details of the protocol modified from the one suggested by 
Choux et al, are as follows: 
1. It is done as a first case in the operative list. 
2. It is done by an experienced surgeon. 
3. Surgeon, Anaesthetist and Staff nurse alone in the operating room. 
4. Skin must be thoroughly prepared and drapped and should not be 
touched during the surgical procedure. 
5. Avoiding autoclaved gloves. 
6. Shunt tube pack must be opened just before its insertion. 
7. Shunt tube should not be immersed in saline for checking the 
valve. 
8. Minimising the duration of surgery. 
9. Peri-operative Antibiotics given for all cases. 
10. Avoiding intermediate skin incisions along shunt tube tract. 
11. Patient advised not to lie over the operated side to avoid pressure 
over the shunt pump. 
FOLLOW-UP: 
 All these patients were followed up by phone interviews and out-
patient reviews for signs and symptoms of shunt infection. 
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DIAGNOSIS OF SHUNT INFECTION: 
                          1. Redness and tenderness along shunt tube tract. 
                 2. Wound gaping and pus discharge of either the 
                     cranial or abdominal wound. 
                 3. Exposed shunt tube anywhere along the tract. 
                 4. Signs of meningeal irritation. 
                 5. Unexplained fever. 
TREATMENT OF INFECTION: 
 The treatment options for shunt infection are  
1. Conservative 
2. Shunt tube removal, treatment of infection, fresh 
Ventriculo-peritoneal shunt. 
 The removed shunt tube was subjected to culture and sensitivity. 
CSF sample was also taken for Biochemical analysis, culture and 
sensitivity and cytology. Blood culture, urine culture, blood widal, 
peripheral smear for malarial parasite, chesy X-RAY was done to rule out 
other causes for fever. Conservative treatment includes treatment with 
antibiotics covering gram positive, gram negative and anaerobes like 
Crystalline penicillin, Gentamicin and  Metronidazole. 
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RESULTS 
 In  Group 1, comprising 80 cases, for whom the shunt was done 
based on the protocol,  none of the cases were infected.  
 In Group 2, comprising 406 cases, where the protocol was not 
followed while doing the shunt, 22 cases got infected between 13days to 
1year. The details about various steps in the protocol and their 
contribution to the incidence of shunt infection are tabulated below:  
Parameter Total cases Infected Percentage 
Not as first case 270 14 5.18 
Emergency 176 4 2.27 
Immersion in saline 368 15 4.07 
H/o previous shunt 14 2 14.28 
No Pre-op antibiotics 393 22 5.59 
Intermediate skin 
incision 
7 1 14.28 
Duration of surgery >1hr 5 1 20 
 
 In the group II comprising 406 cases, where the protocol was not 
followed while doing the shunt, 226 were males and 180 were females. 
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270 cases were not operated as a first case in the operating list,  the shunt 
tube was immersed in saline in 368 cases for checking the valve, the 
shunt was done as an emergency procedure in 176 patients,  previous 
history of shunt was present in 14 of the patients, Pre-op antibiotics was 
not used in 393 patients, Intermediate skin incisions were used in 7 
patients and the duration of surgery lasted for more than an hour in 5 
patients. 
 In a group of  270 patients were shunt was not done as a first case, 
14 patients got infected(5.1%).  Of the 368 patients, whose shunt tube 
was immersed in saline, 15 patients got infected(4.07%).  Of the 176 
patients operated as emergency, 4 patients got infected (2.2%). With 14 
patients already having a shunt done, 2 patients got infected(14.2%). Of  
the 393 patients for whom pre-op antibiotics were not used, 22 patients 
got infected(5.5%). One out of seven patients, for whom intermediate 
skin incisions were used got infected(14.28%). Of the 5 Patients where 
the shunt procedure was lasted for more than one hour, one patient got 
infected(20%).  
 Of the 22 cases which got infected,  36.36% (8 cases) got infected 
in first 2 months following surgery. Of the 91 infants, for whom shunt 
was done, 8 patients got infected(8.79%). 0f the 18 neonates for whom 
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shunt was done, none of them got infected. 6.19% of male shunts and 
4.44% of female shunts got infected. 
 Majority of the shunt infections were seen in aqueductal stenosis, 
followed by tumour associated hydrocephalus. Post- haemorrhagic and 
Post- infective hydrocephalus comes next in the list. Two cases of 
myelomeningocoele associated hydrocephalus got infected. 
 Of all the infected cases, 3 patients were managed conservatively 
with antibiotics, 3 patients were managed with shunt removal only as they 
were shunt independent, the  remaining 16 patients were managed with 
fresh shunt after removing the infected shunt and controlling the 
infection. 
 On subjecting the removed shunt tube for culture, Staph aureus, 
Staph epidermidis and E.coli was grown in three cases respectively. Rest 
of the cultures were negative. 
 The antibiotics used to treat shunt infection were Crystalline 
penicillin, Gentamicin, Metronidazole. In some patients Cefaperazone- 
sulbactum and Piperacillin were also used based on culture and sensitive 
reports. 
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 In a group of 80 patients, for whom shunt was done based on the 
protocol none of the cases got infected. 
Infected Vs Non- Infected in Group I and Group II 
 
 
 
 
 
 The chart comparing the total number of infected and non-infected 
cases in the each of the groups. 
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 The chart depicts the contribution of various factors involved in 
shunt surgery for the development of shunt infection. 
Demographic profile of infected cases 
 
 
 
 The chart showing the demographic profile of the infected cases. 
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STASTICAL ANALYSIS 
Independent Samples Test
-12.860 484.000 .000 -.778 -.572
-28.995 405.000 .000 -.721 -.629
25.602 484.000 .000 .823 .960
57.724 405.000 .000 .861 .922
6.728 484.000 .000 .271 .495
10.426 231.807 .000 .311 .456
.953 484.000 .341 -.026 .074
1.178 145.332 .241 -.016 .065
-49.077 484.000 .000 -1.007 -.929
-110.650 405.000 .000 -.985 -.951
1.182 484.000 .238 -.011 .046
2.666 405.000 .008 .005 .030
.997 484.000 .319 -.012 .037
2.247 405.000 .025 .002 .023
-2.136 484.000 .033 -.104 -.004
-4.817 405.000 .000 -.076 -.032
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
Not as first case
Immersed in saline
Emergency
H/O Previous. Shunt
Antibiotic
Intrmediate incision
duration of surgery
Infected
t df
Sig.
(2-tailed) Lower Upper
95% Confidence Interval
of the Difference
t-test for Equality of Means
 
 For shunts which have not been done as a first case, there is a 
statistically significant difference between controls and patients groups.  
(P-value – 0.000) < (P-value – 0.05). 
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 For the patients where the shunt system was immersed in saline, 
there is statistically significant difference between controls and patients  
groups. (P-value – 0.000) < (P-value – 0.05). 
 For shunts done as an emergency procedure, there is statistically 
significant difference between controls and patients groups. (P-value – 
0.000) < (P-value – 0.05). 
 For patients who already underwent shunt surgery, there is no 
statistically significant difference between controls and patients groups.  
(P-value – 0.341) > (P-value – 0.005). 
 For the use of peri-operative antibiotics, there is statistically 
significant difference between controls and patients groups.  (P-value – 
0.000) < (P-value – 0.005). 
 For patients where an intermediate skin incision was used, there is 
no statistically significant difference between controls and patients 
groups.  (P-value – 0.238) > (P-value – 0.005). 
 For patients where the duration of surgery lasted for more than an 
hour, there is no statistically significant difference between controls and 
patients groups. (P-value – 0.319) > (P-value – 0.005). 
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Crosstabs 
AGE * TYPE Crosstabulation
Count
211 37 248
195 43 238
406 80 486
<=12
>12
AGE
Total
Group II Group I
TYPE
Total
 
Chi-Square Tests
.875b 1 .350
.661 1 .416
.875 1 .349
.392 .208
.873 1 .350
486
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp.
Sig.
(2-sided)
Exact
Sig.
(2-sided)
Exact
Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 39b. 
 
 Inference: Age with Infected and not infected patients between 
groups there is no statistically significant difference, (P-value – 0.350) > 
(P-value – 0.05) i.e Infected and not infected patients between age groups 
are equal. 
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DISCUSSION 
 Thus from the above study it has become clear that by following 
meticulous surgical technique, the shunt infection rate has been reduced 
to 0%. The majority of shunt infections are observed within 2 months of 
its insertion and are a result of probable direct contamination at the time 
of its insertion. In accordance with data in other reports in which the 
infection rate ranged from 3.8 to 27%, the infection rate was 5.4% in our 
Institute. After introduction of this new strategy the infection rate was 
reduced from 5.4% to 0%. In agreement with other studies, more than 
one- third of the infections occurred in children less than 1year of age and 
on the contrary none of the neonates got infected. For patients undergoing 
multiple shunts the infection rate increased from 5.4% to 14.28%. This is 
supported by other studies by George et al and Meirovitch et al. In accord 
with the report of George et al, the experience of the surgeon is the most 
important factor in the reduction of shunt infection rates, we also believe 
that shunt procedure should be carried out only by an experienced 
surgeon. In various literatures, 70 to 75% of shunt infections were caused 
by Staph. epidermidis and 20 to 25% of infections were due to Staph. 
aureus but in our study most of the cultures were negative. Regarding the 
use of prophylactic antibiotics, there is zero infection in the group where 
peri-operative  antibiotics were used. On the contrary 5.4% infection 
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occurred in the group where no peri-operative antibiotics were used. 
Haines and Taylor despite demonstrating the reduction in infection with 
the use of prophylactic antibiotics, were unable to show a statistically 
significant reduction. We routinely use the prophylactic antibiotic at the 
time of induction. On the contrary to various studies, most of the shunt 
infections are seen in aqueductal stenosis patients than those having 
associated myelomeningocoele. Of all the steps described in our protocol, 
prolonged duration of surgery, using intermediate skin incisions and 
patients who already underwent a shunt poses an increased risk of 
developing shunt infection in the range of  20%, 14.28% and 14.28% 
respectively. Use of pre-operative antibiotics and doing shunt as a first 
case in the operative list significantly reduces the incidence of shunt 
infection. 
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        The following chart compares the incidence of  shunt infection in 
various studies:   
Author Year of study No. of cases Infection rate 
George et al 1979 388 12.97% 
Mc cullough et al 1980 223 2.62% 
Duret et al 1983 56 3.54% 
Fitzgerald et al 1984 82 2.43 
Mancao et al 1998 268 10.8% 
Lakshmi et al  2006 226 3.98% 
Thompson et al  2007 108 6.48% 
Inayatullah et al 2009 151 1.98% 
Present study  2010 80 0% 
 
 Thus from the above study, it is clear that attention to detail and 
meticulous surgical technique are important if a high rate of shunt 
infection has to be avoided. This has important implications for the 
obvious and hidden costs for treating repeated shunt infections in our 
patients. 
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CONCLUSION 
 The following conclusions were derived from this study, 
 The shunt infection can be brought to 0% , by observing a simple, 
practicable protocol. (modified from the one suggested by Choux et al , 
1992). 
 In the group, where the protocol was not followed, it is observed 
that prolonged surgery, use of intermediate skin incision and previous 
shunt surgery contribute to increased risk of shunt infection( ranging from 
14 to 20%). Immersion of shunt tube in saline prior to its insertion, non-
usage of peri-operative antibiotics also contributed to increased risk of 
shunt infection, though to a lesser degree. 
S.No. Age Sex I.P. No Diagnosis
First 
case
 Immersed in 
Saline Emergency
H/o Previous 
H1
Shunt
Time 
Since 
Shunt
Persons in 
O.T Treatment
Organisms 
Grown
Peri-op 
Antibiotics
Intrmediate 
Incision
Duration of 
Surgery
1 33 F 6870 Post- trauma hydrocephalus No yes No No 8m More than 3 Shunt removed No Growth No no less than hr
2 21 F 61123 Lt. CP Angle SOL with Hydrocephalus No Yes No No 1yr More than 3 Cons No no less than hr
3 3m M 6116 Aqueductal Stenosis Yes Yes No No 1m More than 3 Shunt removed with opp. Shunt Staph No no less than hr
4 3m M 6428 Aqueductal Stenosis No yes No No 1m More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
5 17 M 20023 Aqueductal Stenosis No No No Yes 13m More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
6 2 M 54326 Post - IVH Hydrocephalus Yes yes No Yes 9m More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
7 5m M 87945 Post - IVH Hydrocephalus No No No No 2m More than 3 Shunt removed with opp. Shunt commensals No no less than hr
8 1 M 71797 Dandy walker mal with hydrocephalus Yes yes No No 5m More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
9 3m M 41234 MMC with Hydrocephalus Yes yes No No 1.5m More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
10 1.5m M 7034 Post- meningitic Hydrocephalus No No Yes No 15days More than 3 Shunt removed with opp. Shunt E.coli No no less than hr
11 1 F 37395 Aqueductal Stenosis Yes yes No No 45days More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
12 5 M 52491 post-meningitic hydrocephalus No No Yes No 7m More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
13 3 F 23509 Aqueductal Stenosis No yes No No 1yr More than 3 Shunt removed with opp. Shunt Staph aureus No no less than hr
14 28 F 101918 Cerebellar SOL with Hydrocephalus No No Yes No 9m More than 3 Cons No no less than hr
15 22 M 100838 Post - IVH Hydrocephalus No No Yes No 21days More than 3 Shunt removed with opp. Shunt No Growth No no more than hr
16 19 M 91948 Sellar SOL with Hydrocephalus Yes yes No No 16m More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
17 38 F 89055 Cerebellar SOL with Hydrocephalus Yes yes No No 10m More than 3 Shunt removed commensals No Yes less than hr
18 5 F 47467 MMC with Hydrocephalus No No No No 1yr More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
19 14 M 52722 post-meningitic hydrocephalus No yes No No 7m More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
20 19 M 52759 Cerebellar SOL with Hydrocephalus No yes No No 6m More than 3 Cons No no less than hr
21 11m M 62950 Aqueductal Stenosis Yes yes No No 13days More than 3 Shunt removed with opp. Shunt No Growth No no less than hr
22 19 F 62967 Cerebellar SOL with Hydrocephalus No yes No No 2m More than 3 Shunt removed No Growth No no less than hr
23 1 F 79276 Cerebellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
24 1 M 81480 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
25 8/ 365 M 81584 Dandy Walker mal with Hydrocephalus yes yes No No More than 3 No Yes less than hr
26 40 F 85625 Sellar SOL with Hydrocephalus No No Yes No More than 3 No no less than hr
27 2 F 84724 Communicating Hydrocephalus No yes No No More than 3 Yes no less than hr
28 1.5m M 93660 Aqueductal stenosis yes yes No No More than 3 Yes no less than hr
29 15/ 365 F 93676 Aqueductal stenosis No yes No No More than 3 No no less than hr
30 3m F 93307 Aqueductal stenosis yes yes No No More than 3 No no less than hr
31 43 F 90101 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
32 6m M 84669 MMC with Hydrocephalus No No No No More than 3 Yes no less than hr
33 8 M 85434 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
34 45 F 85329 SAH with Hydrocephalus No No Yes No More than 3 No no less than hr
35 12 M 91485 Cerebellar SOL with Hydrocephalus No No Yes No More than 3 No no less than hr
36 4 F 80795 Cerebellar SOL with Hydrocephalus No No Yes No More than 3 No no less than hr
37 30 F 71758 Sellar SOL with Hydrocephalus No yes No No More than 3 No Yes less than hr
38 32 F 71750 Cerebellar SOL with Hydrocephalus No No Yes No More than 3 No no less than hr
39 15 F 1191 Cerebellar SOL with Hydrocephalus No No Yes No More than 3 No no less than hr
40 5 F 80108 Cerebellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
41 45 F 80126 Rt. CP Angle SOL with Hydrocephalus No No Yes No More than 3 No no less than hr
42 60 M 80824 Cerebellar SOL with Hydrocephalus No No Yes No More than 3 No no less than hr
43 30 M 82620 Communicating Hydrocephalus yes yes No No More than 3 No no less than hr
44 6 M 80123 Pineal SOL with Hydrocephalus No No No No More than 3 No no less than hr
45 2 M 80103 Post- meningitic Hydrocephalus yes yes No No More than 3 No no less than hr
46 1m F 80094 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
47 3m F 80034 Aqueductal stenosis yes yes No No More than 3 No no less than hr
48 1 M 80009 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
49 8 M 79984 Tuberculoma braim with Hydrocephalus No yes No No More than 3 No no less than hr
50 4 M 79973 Post- meningitic Hydrocephalus yes yes No No More than 3 No no less than hr
51 30 f 79864 Lt.CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
52 56 M 79851 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
53 29 F 79840 Cerebellar SOL with Hydrocephalus No No No No More than 3 No no less than hr
54 10m M 101238 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
55 10m M 101027 Cerebellar SOL with Hydrocephalus yes yes No No More than 3 Yes no less than hr
APPENDIX - 3 
GROUP - II 
INFECTED CASES 
NON INFECTED CASES 
56 4m M 101052 Aqueductal stenosis yes yes No No More than 3 Yes no less than hr
57 40 M 101040 Lt.CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
58 28 M 101046 Trapped lateral ventricle No No Yes No More than 3 No no less than hr
59 28 M 101024 Rt. CP Angle SOL with Hydrocephalus No No Yes No More than 3 No no less than hr
60 2 F 101030 Post- meningitic Hydrocephalus No No No Yes More than 3 No no less than hr
61 1m M 101140 Aqueductal stenosis yes yes No No More than 3 No no less than hr
62 50 F 101156 Cerebellar SOL with Hydrocephalus yes No Yes No More than 3 No no less than hr
63 5 F 79545 Lt. cerebellar SOL with Hydrocephalus No yes No No More than 3 No Yes less than hr
64 1.5m M 79701 Aqueductal stenosis yes yes No No More than 3 No no less than hr
65 2.5 F 79721 Cerebellar SOL with Hydrocephalus No No No No More than 3 No no less than hr
66 20 F 80247 colloid cystwith hydrocephalus No yes No No More than 3 No no less than hr
67 4m M 82586 Aqueductal stenosis No yes No No More than 3 No no more than hr
68 11m F 88066 Aqueductal stenosis No yes No No More than 3 No no less than hr
69 65 F 81646 Lt.CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
70 5 M 82798 Aqueductal stenosis No No No Yes More than 3 No no less than hr
71 7 M 85196 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
72 2.5 M 85214 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
73 11m M 83066 LOCULATED Hydrocephalus yes yes No No More than 3 No no less than hr
74 6m M 84147 Cerebellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
75 25 M 84831 Post- meningitic Hydrocephalus No yes No No More than 3 No Yes less than hr
76 38 M 54133 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
77 21 F 54156 Rec. Meduloblastoma with Hydrocephalus No yes No No More than 3 No no less than hr
78 2.5 F 77362 Aqueductal stenosis yes yes No No More than 3 No no less than hr
79 1.5 F 67385 Aqueductal stenosis No yes No No More than 3 No no less than hr
80 3m M 73021 Aqueductal stenosis yes yes No No More than 3 No no less than hr
81 29 M 72945 Pineal SOL with Hydrocephalus No yes No No More than 3 No no less than hr
82 17/365 f 72421 Aqueductal stenosis yes yes No No More than 3 No no less than hr
83 30 F 72346 Rt. CP Angle SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
84 27 F 74632 Post- meningitic Hydrocephalus yes yes No No More than 3 Yes no less than hr
85 15 F 75643 Post- meningitic Hydrocephalus No yes No No More than 3 No no less than hr
86 11 F 77067 Pineal SOL with Hydrocephalus No yes No No More than 3 No no less than hr
87 29 M 626 Cerebellar SOL with Hydrocephalus yes yes No Yes More than 3 No no less than hr
88 50 F 958 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
89 1m M 1253 Communicating Hydrocephalus yes yes No No More than 3 No no less than hr
90 8m F 2577 Aqueductal stenosis yes No No No More than 3 No no less than hr
91 45 F 3813 Lt.CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
92 4m F 3069 Dandy Walker mal with Hydrocephalus yes No No No More than 3 No no less than hr
93 25 F 1601 Lt.CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
94 1 M 1970 Post- meningitic Hydrocephalus No yes No No More than 3 No no less than hr
95 32 M 3517 Post- meningitic Hydrocephalus No yes No No More than 3 No no less than hr
96 20 F 5814 Aqueductal stenosis yes yes No No More than 3 Yes no less than hr
97 7 F 4357 Post- meningitic Hydrocephalus No yes No No More than 3 No no less than hr
98 1 M 5864 Aqueductal stenosis No yes No No More than 3 No no less than hr
99 2.5 F 7179 Dandy Walker mal with Hydrocephalus No yes No No More than 3 No no less than hr
100 27 M 8554 Post-traumatic hydrocephalus No yes No No More than 3 No no less than hr
101 18 M 802 Post-traumatic hydrocephalus No yes No No More than 3 No no less than hr
102 7 M 6818 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No Yes more than hr
103 9 F 9801 Sellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
104 1m M 15768 Aqueductal stenosis yes yes No No More than 3 No no less than hr
105 2M f 45611 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
106 6m F 45670 Aqueductal stenosis No yes No Yes More than 3 No no less than hr
107 18 M 46307 colloid cystwith hydrocephalus No yes No No More than 3 No no less than hr
108 31 M 46347 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
109 31 F 47996 Post-meningitic Hydrocephalus No yes No No More than 3 No no less than hr
110 25 M 49120 Adult aqueductal stenosis No yes No No More than 3 No no less than hr
111 8 F 30069 MMC with Hydrocephalus yes yes No Yes More than 3 No no less than hr
112 23 M 47246 Sellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
113 85 M 47562 NPH No yes No No More than 3 No no less than hr
114 3 F 51646 Sellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
115 70 M 51982 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
116 17 F 52446 Communicating Hydrocephalus yes yes No No More than 3 No no less than hr
117 50 M 51116 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 Yes no less than hr
118 10days F 52987 MMC with Hydrocephalus yes No No No More than 3 Yes no less than hr
119 18days F 53016 MMC with Hydrocephalus No yes No No More than 3 No no less than hr
120 45 M 51224 Communicating Hydrocephalus No yes No No More than 3 No no less than hr
121 7m M 50615 LOCULATED Hydrocephalus No yes No No More than 3 No no less than hr
122 1m F 54870 Aqueductal stenosis yes No No No More than 3 No Yes less than hr
123 8m M 50528 Communicating Hydrocephalus yes yes No No More than 3 No no less than hr
124 30 F 52540 Rec. PITUITARY ADENOMA No yes No No More than 3 No no less than hr
125 35 F 54334 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
126 13 M 57766 Lt.CP Angle SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
127 28 M 58780 Cerebellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
128 47 M 58788 Post- fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
129 66 m 59048 Pineal SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
130 6m M 57779 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
131 3m F 59397 Aqueductal stenosis No yes No No More than 3 No no less than hr
132 40 F 54228 Communicating Hydrocephalus yes yes No No More than 3 No no less than hr
133 35 F 60923 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
134 1 F 57811 MMC with Hydrocephalus No yes No No More than 3 No no less than hr
135 5m F 51244 Aqueductal stenosis yes yes No No More than 3 No no less than hr
136 4m M 63639 Aqueductal stenosis No yes No No More than 3 No no less than hr
137 35 F 59580 Post-meningitic Hydrocephalus yes yes No No More than 3 No no less than hr
138 34 M 61092 Post-meningitic Hydrocephalus No yes No No More than 3 No no more than hr
139 10 F 59066 Post-meningitic Hydrocephalus No yes No No More than 3 No no less than hr
140 11m F 62273 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
141 27 M 65934 Post-meningitic Hydrocephalus No yes No No More than 3 No no less than hr
142 2.5 F 53020 LOCULATED Hydrocephalus yes yes No No More than 3 No no less than hr
143 1 m 66453 Aqueductal stenosis yes yes No Yes More than 3 No no less than hr
144 16 F 66852 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
145 1m M 68232 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
146 22 M 70273 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
147 2.5 F 70579 Cerebellar SOL with Hydrocephalus yes No No No More than 3 No no less than hr
148 8m F 70951 Aqueductal stenosis No yes No No More than 3 No no less than hr
149 7 M 67107 Aqueductal stenosis No yes No No More than 3 No no less than hr
150 25days M 73260 Aqueductal stenosis yes yes No No More than 3 Yes no less than hr
151 1.5m M 76077 Communicating Hydrocephalus yes No No No More than 3 Yes no less than hr
152 13 M 76132 Brainstem SOL with Hydrocephalus No yes No No More than 3 No no less than hr
153 30 F 76103 FM SOL with Hydrocephalus No yes No No More than 3 No no less than hr
154 2m M 74811 Aqueductal stenosis yes yes No No More than 3 No no less than hr
155 55 F 76782 Post- fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
156 4m M 72560 Aqueductal stenosis yes yes No No More than 3 No no less than hr
157 45 M 78984 Communicating Hydrocephalus No yes No No More than 3 No no less than hr
158 1m F 76802 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
159 3m F 80280 Communicating Hydrocephalus No yes No No More than 3 No no less than hr
160 1.5m M 84572 Communicating Hydrocephalus yes No No No More than 3 No no less than hr
161 5m F 84908 Aqueductal stenosis yes yes No No More than 3 No no less than hr
162 2 F 83323 Aqueductal stenosis yes yes No No More than 3 No no less than hr
163 5m F 84169 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
164 2m M 84118 Dandy Walker mal with Hydrocephalus No yes No No More than 3 No no less than hr
165 6 F 90867 Sellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
166 28 M 91381 Post-meningitic Hydrocephalus No yes No No More than 3 No no less than hr
167 1m M 89987 Aqueductal stenosis yes yes No No More than 3 No no less than hr
168 67 M 88931 NPH No yes No No More than 3 No no less than hr
169 6 F 96394 Post-fossa SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
170 5 F 97116 Pineal SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
171 2 M 96506 Post-meningitic Hydrocephalus No yes No No More than 3 No no less than hr
172 1m M 100484 Post-meningitic Hydrocephalus No yes No No More than 3 No no less than hr
173 1m F 1989 Post-meningitic Hydrocephalus No yes No No More than 3 No no less than hr
174 48 M 1858 Lt.CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
175 6m M 1835 Dandy Walker mal with Hydrocephalus yes yes No No More than 3 No no less than hr
176 25 M 2169 Rt. CP Angle SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
177 2m M 341 MMC with Hydrocephalus yes yes No No More than 3 No no less than hr
178 40 F 2985 Post-fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
179 10days F 3490 Occipital encephalocoele with Hydrocephalu yes yes No No More than 3 No no less than hr
180 2 M 7391 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
181 3m M 4382 Aqueductal stenosis yes yes No No More than 3 No no less than hr
182 9 F 6451 Pineal SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
183 4m F 5155 MMC with Hydrocephalus yes No No No More than 3 No no less than hr
184 7 M 7852 Post-fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
185 1.5 M 2125 Dandy Walker mal with Hydrocephalus yes No No No More than 3 No no less than hr
186 5m M 9711 MMC with Hydrocephalus No No No No More than 3 No no less than hr
187 22 M 9769 Post-traumatic hydrocephalus yes No No No More than 3 No no less than hr
188 35 M 9772 Post-traumatic hydrocephalus No No No No More than 3 No no less than hr
189 7m M 6547 Aqueductal stenosis yes yes No No More than 3 No no less than hr
190 6m M 8484 Aqueductal stenosis No yes No No More than 3 No no less than hr
191 55 F 11719 Cerebellar SOL with Hydrocephalus yes No No No More than 3 No no less than hr
192 7 M 12765 Pineal SOL with Hydrocephalus No yes No Yes More than 3 No no less than hr
193 37 M 13456 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
194 4m M 11775 Aqueductal stenosis No yes No No More than 3 No no less than hr
195 43 F 14926 Tentorial meningioma with Hydrocephalu yes No No No More than 3 No no less than hr
196 33 M 15460 Trapped lateral ventricle No yes No Yes More than 3 No no less than hr
197 1m F 15768 Aqueductal stenosis yes No No No More than 3 No no less than hr
198 7m F 16686 Aqueductal stenosis No yes No No More than 3 No no less than hr
199 1 F 15206 Aqueductal stenosis No yes No No More than 3 No no less than hr
200 47 M 7271 Lt.CP Angle SOL with Hydrocephalus yes No No No More than 3 No no less than hr
201 3m M 17845 Aqueductal stenosis yes yes No No More than 3 No no less than hr
202 36 F 19676 Post-fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
203 3 M 15221 Aqueductal stenosis No yes No No More than 3 No no less than hr
204 2m M 15199 Occipital encephalocoele with Hydrocephalu yes yes No No More than 3 No no less than hr
205 1 F 18832 Sellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
206 30 F 82620 Communicating Hydrocephalus No yes No No More than 3 No no less than hr
207 60 M 80824 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
208 45 F 80126 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
209 5 F 80108 Post-fossa SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
210 15 F 3340 Post-fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
211 1 F 79276 Cerebellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
212 1 M 81480 Post-fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
213 8days M 81365 Dandy Walker mal with Hydrocephalus yes No No No More than 3 No no less than hr
214 40 F 85615 Sellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
215 1.5 F 50593 Post-meningitic Hydrocephalus yes yes Yes No More than 3 No no less than hr
216 39 F 46717 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
217 6 M 45123 Aqueductal stenosis yes yes No No More than 3 No no less than hr
218 1 F 45132 Aqueductal stenosis No yes No No More than 3 No no less than hr
219 13 F 47541 Aqueductal stenosis yes yes No No More than 3 No no less than hr
220 2 M 48441 Tuberculoma braim with Hydrocephalus yes yes No No More than 3 No no less than hr
221 28 M 52665 Post-fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
222 17 M 54491 Post-fossa SOL with Hydrocephalus No yes No No More than 3 No no less than hr
223 45 F 51015 colloid cystwith hydrocephalus No yes No No More than 3 No no less than hr
224 4 M 51060 Sellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
225 40 F 51173 Lt.CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
226 16 M 54336 Post-meningitic Hydrocephalus yes No No No More than 3 No no less than hr
227 1m F 54487 Aqueductal stenosis yes No No No More than 3 No no less than hr
228 50 F 52740 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
229 3m F 53306 Aqueductal stenosis yes yes No No More than 3 Yes no less than hr
230 37 F 52361 Aqueductal stenosis No yes No No More than 3 No no less than hr
231 1.5 M 55729 Post-meningitic Hydrocephalus yes yes No No More than 3 No no less than hr
232 3m F 53016 MMC with Hydrocephalus No yes No No More than 3 No no less than hr
233 2m M 55060 Aqueductal stenosis yes yes No No More than 3 No no less than hr
234 5 M 55063 Aqueductal stenosis No yes No No More than 3 No no less than hr
235 55 F 54050 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
236 5 M 52491 Cerebellar SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
237 3m F 52504 Post-meningitic Hydrocephalus No yes No No More than 3 No no less than hr
238 20 M 54697 Cerebellar SOL with Hydrocephalus No yes No No More than 3 No no less than hr
239 33 M 58176 Post- traumatic Hydrocephalus No yes No No More than 3 No no less than hr
240 20 M 57101 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
241 32 M 61153 Cerebellar SOL with Hydrocephalus yes No No No More than 3 No no less than hr
242 27 F 58915 Rt. CP Angle SOL with Hydrocephalus No yes No No More than 3 No no less than hr
243 30 M 63643 Post-fossa SOL with Hydrocephalus yes yes No No More than 3 No no less than hr
244 3m F 23763 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
245 3m M 27871 MMC with Hydrocephalus No yes Yes No More than 3 No no less than hr
246 30 M 28177 Rt. CP Angle SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
247 7 G 28095 Suprasellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
248 24 F 29173 Lt.CP Angle SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
249 40 F 29390 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
250 11 F 30083 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
251 28 M 27641 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
252 47 F 30720 Post-fossa SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
253 10m F 31010 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
254 11 F 31332 Aqueductal stenosis No yes Yes No More than 3 No no more than hr
255 16 F 32980 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
256 55 F 33844 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
257 6 M 35440 Cerebellar SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
258 2 F 37035 Aqueductal stenosis No yes Yes Yes More than 3 No no less than hr
259 30 M 38008 Post-traumatic hydrocephalus No yes Yes No More than 3 No no less than hr
260 9 M 34952 Aqueductal stenosis No yes Yes Yes More than 3 No no less than hr
261 55 M 36123 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
262 30 M 35710 Intraventricular SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
263 13 M 42543 Cerebellar SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
264 2m F 1899 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
265 7m f 30612 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
266 25 M 43503 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
267 25 F 42865 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
268 3m M 44836 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
269 71 M 45037 NPH No yes Yes No More than 3 No no less than hr
270 5 M 43870 Cerebellar SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
271 29 M 45173 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
272 10 M 40240 Cerebellar SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
273 44 M 5088 Rt. CP Angle SOL with Hydrocephalus No yes Yes Yes More than 3 No no less than hr
274 36 M 52445 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
275 21 F 50265 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
276 65 M 53441 NPH No yes Yes No More than 3 No no less than hr
277 14 M 55671 Post-fossa SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
278 6 M 56476 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
279 13 F 54710 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
280 4.5 F 55601 Post-fossa SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
281 11 M 57249 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
282 2.5m M 57220 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
283 35 F 57831 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
284 73 M 55740 NPH No yes Yes No More than 3 No no less than hr
285 4 F 60129 Suprasellar SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
286 38 M 60181 Lt.CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
287 2.5m M 62387 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
288 3 F 51644 Suprasellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
289 50 F 62046 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
290 11m M 62950 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
291 8m F 63700 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
292 14 F 92160 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
293 6m F 61244 Aqueductal stenosis No yes Yes Yes More than 3 No no less than hr
294 35 M 57831 Rt. CP Angle SOL with Hydrocephalus No yes Yes Yes More than 3 No no less than hr
295 5m F 64948 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
296 14 F 66505 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
297 13 M 65070 Post-fossa SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
298 63 M 66299 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
299 11 M 67335 Post-meningitic Hydrocephalus yes yes Yes No More than 3 No no less than hr
300 4m F 68180 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
301 8m M 68477 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
302 2m M 68605 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
303 2 F 68580 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
304 23 F 68897 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
305 24 F 68264 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
306 9 m 69702 Cerebellar SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
307 31 M 69501 Communicating Hydrocephalus No yes Yes No More than 3 No no less than hr
308 5 F 71001 Obstructive Hydrocephalus yes yes Yes No More than 3 No no less than hr
309 32 F 55601 Lt.CP Angle SOL with Hydrocephalus No yes Yes No More than 3 Yes no less than hr
310 8 M 71051 Obstructive Hydrocephalus yes yes Yes No More than 3 No no less than hr
311 33 M 71786 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
312 19 M 84164 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
313 5 F 72445 Post-fossa SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
314 43 M 72286 Suprasellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
315 50 M 70280 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
316 45 M 73779 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
317 33 M 71786 Lt.CP Angle SOL with Hydrocephalus No yes Yes Yes More than 3 No no less than hr
318 3m F 74573 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
319 12 M 74813 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
320 9m M 73151 Aqueductal stenosis No yes Yes Yes More than 3 No no less than hr
321 3 M 75131 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
322 9 M 74376 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
323 30 M 74894 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
324 2 M 77340 Post-fossa SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
325 7 M 77355 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
326 6 F 76203 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
327 4 M 78920 Post-fossa SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
328 68 M 79487 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
329 1.5m M 76277 MMC with Hydrocephalus yes yes Yes No More than 3 No no less than hr
330 5 M 80106 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
331 50 M 80502 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
332 27 M 80134 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
333 16 M 81367 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
334 57 F 81998 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
335 45 F 78803 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
336 4 F 82938 Post-fossa SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
337 32 F 83041 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
338 23 M 82750 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
339 50 M 83428 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
340 48 M 83644 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
341 24 F 79269 Rt. CP Angle SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
342 52 M 81730 NPH No yes Yes No More than 3 No no less than hr
343 22 M 84780 Aqueductal stenosis No yes Yes Yes More than 3 No no less than hr
344 25 M 85621 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
345 19 F 87563 Communicating Hydrocephalus No yes Yes No More than 3 No no less than hr
346 33 M 87883 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
347 38 F 89055 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
348 1.1 M 89859 Aqueductal stenosis No yes Yes Yes More than 3 No no less than hr
349 35 F 89778 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
350 7 M 88784 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
351 18 M 90007 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
352 27 M 91945 Rt. CP Angle SOL with Hydrocephalus No yes Yes Yes More than 3 No no less than hr
353 6m F 95131 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
354 55 F 95391 Communicating Hydrocephalus No yes Yes No More than 3 No no less than hr
355 3 M 96072 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
356 1 M 97017 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
357 5 M 96382 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
358 7m M 99636 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
359 4 M 99509 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
360 20 M 100203 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
361 35 F 91762 SAH with Hydrocephalus No yes Yes No More than 3 No no less than hr
362 15 M 2177 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
363 44 M 1905 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
364 55 F 2495 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
365 19 M 3458 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
366 22 M 1714 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
367 3 M 5844 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
368 20 M 5085 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
369 9 F 6910 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
370 49 M 7405 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
371 6 M 7810 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
372 22 M 7402 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
373 56 F 8522 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
374 19 F 9443 Suprasellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
375 8m M 8416 Cerebellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
376 35 F 9176 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
377 40 M 10080 Obstructive Hydrocephalus No yes Yes No More than 3 No no less than hr
378 4 M 12827 Post-fossa SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
379 3m M 8528 MMC with Hydrocephalus No yes Yes No More than 3 No no less than hr
380 18 M 15309 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
381 2 M 16582 Post-meningitic Hydrocephalus yes yes Yes No More than 3 No no less than hr
382 39 F 16851 Suprasellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
383 80 M 18001 Cerebellar ICH No yes Yes No More than 3 No no less than hr
384 4m M 19055 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
385 2 F 6743 Post-fossa SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
386 1.5m F 19451 MMC with Hydrocephalus No yes Yes No More than 3 No no less than hr
387 45 F 21050 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
388 2 M 42632 Communicating Hydrocephalus No yes Yes No More than 3 No no less than hr
389 23 F 43207 Sellar SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
390 63 M 39799 Post-traumatic hydrocephalus No yes Yes No More than 3 No no less than hr
391 46 F 46544 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
392 1 m 41276 Post-fossa SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
393 1 F 40850 Aqueductal stenosis yes yes Yes No More than 3 No no less than hr
394 42 M 38588 Post-fossa SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
395 3m F 40256 MMC with Hydrocephalus No yes Yes No More than 3 No no less than hr
396 15 M 3766 Suprasellar SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
397 9 M 34333 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
398 16days F 37411 Aqueductal stenosis No yes Yes No More than 3 No no less than hr
399 44 F 36454 Lt.CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
400 6 F 35200 Post-fossa SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
401 9 F 31226 Communicating Hydrocephalus No yes Yes No More than 3 No no less than hr
402 18 F 31457 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
403 36 M 31420 Rt. CP Angle SOL with Hydrocephalus No yes Yes No More than 3 No no less than hr
404 18 M 31500 Post-fossa SOL with Hydrocephalus yes yes Yes No More than 3 No no less than hr
405 70 m 31517 NPH No yes Yes No More than 3 No no less than hr
406 14 F 31510 Post-meningitic Hydrocephalus No yes Yes No More than 3 No no less than hr
S.No. Age Sex IP. N o Diagnosis
First 
case
Immersed 
In saline Emergency
2nd time 
shunt
Persons 
in OT
Peri-operative 
antibiotics
Intermediate 
skin incision
1 17 F 19237 Post- meningitic Hydrocephalus Yes No No No 3 Yes No
2 28 M 58780 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
3 28 M 58794 Sellar SOL with Hydrocephalus Yes No No No 3 Yes No
4 33 M 72773 Trapped lateral ventricle Yes No No No 3 Yes No
5 8m M 71507 Aqueductal Stenosis Yes No No No 3 Yes No
6 14 F 66505 Post- fossa SOL with Hydrocephalus Yes No No No 3 Yes No
7 26 M 69104 Colloid cyst with Hydrocephalus Yes No Yes No 3 Yes No
8 2.5 F 78599 Aqueductal Stenosis Yes No No No 3 Yes No
9 3m F 97055 Aqueductal Stenosis Yes No No No 3 Yes No
10 30 M 34862 Tuberculoma with Hydrocephalus Yes No No No 3 Yes No
11 8 F 1664 Sellar SOL with Hydrocephalus Yes No No No 3 Yes No
12 35 M 94446 Obstructive Hydrocephalus Yes No Yes No 3 Yes No
13 1 F 418 Aqueductal Stenosis Yes No No No 3 Yes No
14 40 F 44695 Lt. CP Angle SOL with Hydrocephalus Yes No No No 3 Yes No
15 48 F 45558 Lt. CP Angle SOL with Hydrocephalus Yes No No No 3 Yes No
16 30 M 41261 Post-Traumatic Hydrocephalus Yes No No No 3 Yes No
17 59 M 21439 Cerebellar SOL with Hydrocephalus Yes No Yes No 3 Yes No
18 27 F 27283 Post- fossa SOL with Hydrocephalus Yes No No No 3 Yes No
19 21 F 61123 Lt. CP Angle SOL with Hydrocephalus Yes No No No 3 Yes No
20 5 M 52491 Post- fossa SOL with Hydrocephalus Yes No No No 3 Yes No
21 36 F 60491 Obstructive Hydrocephalus Yes No No No 3 Yes No
22 45 F 84421 Lt. CP Angle SOL with Hydrocephalus Yes No No No 3 Yes No
23 14 F 89133 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
24 29 M 90829 Rt.CP Angle SOL WITH hydrocephalus Yes No Yes No 3 Yes No
25 47 F 88006 Lt. CP Angle SOL with Hydrocephalus Yes No Yes No 3 Yes No
26 23 F 43207 Sellar SOL with Hydrocephalus Yes No No No 3 Yes No
27 1 F 85193 Aqueductal Stenosis Yes No No No 3 Yes No
APPENDIX - 3 
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28 1 F 86120 Pineal SOL with HYDROCEPHALUS Yes No No No 3 Yes No
29 21 M 17875 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
30 2.5 M 17904 Tuberculoma with Hydrocephalus Yes No No No 3 Yes No
31 1.5 F 16350 Communicating Hydrocephalus Yes No No No 3 Yes No
32 4m M 23214 Aqueductal Stenosis Yes No No No 3 Yes No
33 1.5 M 7815 MMC with HYDROCEPHALUS Yes No No No 3 Yes No
34 31 M 6804 Sellar SOL with Hydrocephalus Yes No No No 3 Yes No
35 45 M 21185 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
36 52 F 25736 Lt. CP Angle SOL with Hydrocephalus Yes No No No 3 Yes No
37 8m F 30069 MMC with HYDROCEPHALUS Yes No No No 3 Yes No
38 6 F 30104 POST- FOssa SOL with Hydrocephalus Yes No No No 3 Yes No
39 1 m 41276 Post- fossa SOL with Hydrocephalus Yes No No No 3 Yes No
40 11 M 96102 Post- fossa SOL with Hydrocephalus Yes No No No 3 Yes No
41 8 F 1664 Sellar SOL with Hydrocephalus Yes No No No 3 Yes No
42 32 M 6246 Communicating Hydrocephalus Yes No No No 3 Yes No
43 55 M 6922 Communicating Hydrocephalus Yes No No No 3 Yes No
44 30days F 30069 MMC with HYDROCEPHALUS Yes No No No 3 Yes No
45 45 F 32799 Supraselar SOL with Hydrocephalus Yes No No No 3 Yes No
46 5m M 26737 MMC with HYDROCEPHALUS Yes No No No 3 Yes No
47 1 M 31235 Aqueductal Stenosis Yes No No No 3 Yes No
48 6m F 12188 Aqueductal Stenosis Yes No No No 3 Yes No
49 40 F 28203 Lt. CP Angle SOL with Hydrocephalus Yes No No No 3 Yes No
50 20days F 21560 Dandy Walker Malformation with Hydrocepha Yes No No No 3 Yes No
51 8 F 26448 Intraventricular SOL with Hydrocephalus Yes No No No 3 Yes No
52 5 M 27039 Aqueductal Stenosis Yes No No No 3 Yes No
53 11m F 26933 Aqueductal Stenosis Yes No No No 3 Yes No
54 3m M 15142 MMC with HYDROCEPHALUS Yes No No No 3 Yes No
55 13days F 20960 Aqueductal Stenosis Yes No No No 3 Yes No
56 28 M 25740 Post- meningitic Hydrocephalus Yes No No No 3 Yes No
57 8m M 13052 Aqueductal Stenosis Yes No No No 3 Yes No
58 12 m 23275 Supraselar SOL with Hydrocephalus Yes No No No 3 Yes No
59 1 M 23014 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
60 4m M 23123 MMC with HYDROCEPHALUS Yes No No No 3 Yes No
61 3 F 23167 MMC with HYDROCEPHALUS Yes No No No 3 Yes No
62 1 F 23197 Post- meningitic Hydrocephalus Yes No No No 3 Yes No
63 67 M 23267 NPH Yes No No No 3 Yes No
64 5 M 23280 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
65 18 F 23285 Rt.CP Angle SOL WITH hydrocephalus Yes No No No 3 Yes No
66 28 M 23287 Post-Traumatic Hydrocephalus Yes No No Yes 3 Yes No
67 45 M 23314 Post- fossa SOL with Hydrocephalus Yes No No No 3 Yes No
68 30 M 23326 Rt.CP Angle SOL WITH hydrocephalus Yes No No No 3 Yes No
69 18 m 23367 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
70 80 M 23389 NPH Yes No No No 3 Yes No
71 45 F 24010 Rt.CP Angle SOL WITH hydrocephalus Yes No No No 3 Yes No
72 23 F 24015 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
73 12days F 24028 MMC with HYDROCEPHALUS Yes No No No 3 Yes No
74 45days M 24098 Aqueductal Stenosis Yes No No Yes 3 Yes No
75 2m M 25124 Aqueductal Stenosis Yes No No No 3 Yes No
76 32 M 25136 Lt. CP Angle SOL with Hydrocephalus Yes No No No 3 Yes No
77 30 M 26014 Cerebellar SOL with Hydrocephalus Yes No No No 3 Yes No
78 19 M 26074 Supraselar SOL with Hydrocephalus Yes No No No 3 Yes No
79 24 M 26090 Sellar SOL with Hydrocephalus Yes No No No 3 Yes No
80 35 F 26099 Rt.CP Angle SOL WITH hydrocephalus Yes No No No 3 Yes No
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APPENDIX – 1  
PROFORMA OF STUDY 
Patient’s name: 
Age:                                          Sex: 
I.P.No.                                      MIN.No. 
D.O.A                                       D.O.D 
Address:                                   Contact no. 
Presenting complaints: 
Clinical examination: 
Radiology: 
Treatment: 
D/B:                                                  A/B: 
 
Whether done as first case? 
Whether shunt tube immersed in saline? 
Whether done as emergency? 
H/o previous shunt: 
Whether pre-op antibiotics given? 
Whether intermediate skin incision used? 
Duration of surgery: 
Follow-up: 
APPENDIX – 2  
PATIENT CONSENT FORM 
STUDY TITLE: 
Study centre      : Department of Neurosurgery, MMC, Chennai – 600003. 
Patient’s name  : 
Patient’s age     : 
Identification No:  
Patient may check () these boxes 
 I confirm that I have understood the purpose of this study. I have 
the opportunity to ask the questions and all my questions and doubts were 
answered to the best of my satisfaction. 
 I understand that my participation in the study is voluntary and that 
I am free to withdraw at anytime without my legal right being affected. 
 I understand that sponsor of the clinical study. Other’s working on 
the sponsor’s behalf, the ethic’s committee and the regulatory authorities 
will not need my permission to look at my health records both in respect 
of the current study and any further research that may be conducted in 
relation n to it, even if I withdraw from the study. I agree to this access, 
however, I understand that my identity would not be revealed. In any 
information released to the third parties or published, unless as required 
under the law. I agree not to restrict the use of any data or results that 
arise from this study. 
 I agree to take part in the above study and to comply with the 
instructions given during the study and to faithfully to cooperate with the 
study team, and to immediately inform inform the study staff if I suffer 
from any deterioration in my health or my well being or any expected or 
unusual symptoms. 
I hereby give consent to participate in this study. 
Signature/ Thumb impression of the patient: 
Place: 
Patient’s name and address: 
Signature of the investigator: 
Name of the investigator: 
 
 
